...
首页> 外文期刊>Bioorganic and medicinal chemistry >Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligands.
【24h】

Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligands.

机译:新型阿片激动剂和神经激肽-1拮抗剂二价配体的合成和生物学评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Newly designed bivalent ligands-opioid agonist/NK1-antagonists have been synthesized. The synthesis of new starting materials-carboxy-derivatives of Fentanyl (1a-1c) was developed. These products have been transformed to 'isoimidium perchlorates' (2a-c). The new isoimidium perchlorates have been successfully implemented in nucleophilic addition reactions, with l-tryptophan 3,5-bis(trifluoromethyl)benzyl ester to give the target compounds-amides (3a-c). Perchlorates (2a-c) successfully undergo reactions with other nucleophiles such as alcohols, amines or hydrazines. The obtained compound 3b exhibited mu-opioid agonist activity and NK1-antagonist activity and may serve as a useful lead compound for the further design of a new series of opioid agonist/NK1-antagonist compounds.
机译:合成了新设计的二价配体-阿片样物质激动剂/ NK1-拮抗剂。开发了新的原料-芬太尼的羧基衍生物(1a-1c)的合成。这些产物已被转化为“高氯酸亚氨基钠”(2a-c)。新的高氯酸异亚胺钠盐已成功地与1-色氨酸3,5-双(三氟甲基)苄基酯发生亲核加成反应,得到目标化合物-酰胺(3a-c)。高氯酸盐(2a-c)成功地与其他亲核试剂如醇,胺或肼发生反应。所获得的化合物3b表现出μ阿片样物质激动剂活性和NK1拮抗剂活性,并且可以用作进一步设计新系列阿片样物质激动剂/ NK1拮抗剂的有用的先导化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号